Rajani Dinavahi Appointed Chief Medical Officer of Ardelyx

Ardelyx, Inc. has appointed Rajani Dinavahi, MD, as its new Chief Medical Officer. Dr. Dinavahi brings extensive experience in the biopharmaceutical industry, focusing on the development of novel therapies. Her appointment is a strategic move for Ardelyx as it continues its work in developing treatments for specific diseases. This leadership addition is expected to bolster the company's research and development efforts. Ardelyx is committed to advancing its pipeline and bringing innovative medicines to patients in need.